BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5730694)

  • 1. [Osteomyelofibrosis with Philadelphia (Ph1) chromosome].
    Frey I; Siebner H
    Med Welt; 1968 Oct; 42():2274 passim. PubMed ID: 5730694
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chromosome findings in myeloproliferative diseases].
    Hellriegel KP
    Internist (Berl); 1968 Dec; 9(12):465-70. PubMed ID: 4891471
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential diagnostic significance of the Ph chromosome].
    Hampel KE
    Verh Dtsch Ges Inn Med; 1967; 73():457-60. PubMed ID: 5242223
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems of the myeloproliferative syndrome from the clinician's viewpoint].
    Stobbe H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):217-26. PubMed ID: 4184584
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the Ph1 chromosome in a group of chronic myeloproliferative syndromes].
    Mide de Piterbarg S; Bomchil G
    Sangre (Barc); 1969; 14(2):205-14. PubMed ID: 5804343
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytogenetic studies in Philadelphia chromosome-negative myeloproliferative disorders, particularly polycythaemia rubra vera.
    Lawler SD
    Clin Haematol; 1980 Feb; 9(1):159-74. PubMed ID: 6768481
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chromosome aberrations in malignant blood diseases].
    Engel E; McKee LC; Engel-de Montmollin M
    Union Med Can; 1968 Jul; 97(7):901-6. PubMed ID: 5709532
    [No Abstract]   [Full Text] [Related]  

  • 8. Karyotype of mitotic cells in haematopoietic diseases.
    Dieska D; Izakovic V; Gocárová K
    Rev Czech Med; 1974; 20(2):49-57. PubMed ID: 4829332
    [No Abstract]   [Full Text] [Related]  

  • 9. [How to assess a bone-marrow oligoblastosis in apparently normal subjects or those without a definite proliferative hemopathy].
    Woessner S; Sans-Sabrafen J; Lafuente R; Florensa L
    Sangre (Barc); 1984; 29(2):164-73. PubMed ID: 6382648
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reduction of Ph1 chromosome in atypical myeloproliferative disorder by intensive chemotherapy].
    Takeyama H; Yano K; Fukutani H; Yamamoto F; Watanabe E; Satake T
    Rinsho Ketsueki; 1986 Sep; 27(9):1640-4. PubMed ID: 3468279
    [No Abstract]   [Full Text] [Related]  

  • 11. [Familial myeloproliferative syndrome].
    Tatti V; Marfurt P; Sirchia G; Pescia G; Luscieti P; Losa G
    Schweiz Med Wochenschr; 1984 Feb; 114(6):196-204. PubMed ID: 6701501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information.
    Bacher U; Haferlach T; Kern W; Hiddemann W; Schnittger S; Schoch C
    Ann Hematol; 2005 Apr; 84(4):250-7. PubMed ID: 15692838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing cytogenetic picture in an acute myeloproliferative disorder.
    Berry EW; Desforges JF
    Am J Med; 1969 Aug; 47(2):299-305. PubMed ID: 5808243
    [No Abstract]   [Full Text] [Related]  

  • 14. [Sideroblastosis and erythroblastic P.A.S. in leukemias and myeloproliferative syndromes].
    Zittoun R; Guillerm M; Bilski-Pasquier G; Bousser J
    Rev Fr Etud Clin Biol; 1967 Dec; 12(10):972-80. PubMed ID: 5244669
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythroleukaemia.
    Falkson G; Falkson HC
    S Afr Med J; 1968 Dec; 42(47):1291-2. PubMed ID: 5252320
    [No Abstract]   [Full Text] [Related]  

  • 16. Spontaneous chromosome aberrations in bone marrow cells of monkeys.
    Markaryan DS; Avdzhian MV; Machavariani MG
    Sov Genet; 1971 Jun; 7(6):795-9. PubMed ID: 5005878
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incidence of chromosome aberrations in the bone marrow of monkeys and their progeny after exposure to aflatoxin B1].
    Adzhigitov FI; Kosichenko LP; Popandopulo PG; Gubeladze DA; Dzhemilev ZA
    Tsitol Genet; 1984; 18(3):173-6. PubMed ID: 6431671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chromosomic characteristics associated with leukemia and other hemopathies in Costa Rica].
    Castro Volio I; Montero Umaña C; Jiménez Cruz G
    Rev Biol Trop; 1993 Dec; 41(3A):385-92. PubMed ID: 7701079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloproliferative disorders: III. CML: Further studies on the role of cytogenetics in diagnosis, prognosis and management.
    Fuscaldo KE; Brodsky I; Kahn SB; Conroy JF; Marfurt K
    Haematologica; 1981 Aug; 66(4):461-88. PubMed ID: 6797881
    [No Abstract]   [Full Text] [Related]  

  • 20. The timely detection of treatable disease. Hematology.
    Desforges JF
    J Maine Med Assoc; 1980 Jul; 71(7):218-22, 227. PubMed ID: 7391698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.